Education
About Us
Working with TipRanks
Follow Us
BKSE - ETF AI Analysis
Top Page
BNY Mellon US Small Cap Core Equity ETF (BKSE)
Rating:64Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The ETF has a very low expense ratio, making it cost-effective for investors compared to similar funds.
Strong Year-to-Date Performance
The fund has delivered solid year-to-date returns, indicating strong overall performance in 2023.
Sector Diversification
The ETF is spread across multiple sectors, including technology, financials, and industrials, reducing reliance on any single industry.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, offering minimal exposure to international markets.
Small Top Holdings Impact
The top holdings have relatively small weights, which may limit their ability to significantly drive overall fund performance.
Limited Asset Size
The fund has relatively low assets under management, which could lead to less liquidity and higher trading costs for investors.
BKSE vs. SPDR S&P 500 ETF (SPY)
AUM61.97M
RegionNorth America
Expense Ratio0.04%
Beta1.01
IssuerBNY Mellon
Inception DateApr 09, 2020
Dividend Yield1.24%
Asset ClassEquity
Index TrackedSolactive GBS United States 600 Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,375
30 Day Avg. Volume1,413
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
134.48Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering598
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BKSE Summary
The BNY Mellon US Small Cap Core Equity ETF (Ticker: BKSE) is an investment fund that focuses on small-cap companies in the United States, offering exposure to emerging businesses with growth potential. It tracks the Solactive GBS United States 600 Index, which includes a diverse range of industries like technology, financials, and healthcare. Some of its top holdings include Bloom Energy and SanDisk Corp, which are known for their innovation and market presence. This ETF might appeal to investors looking for diversification and the opportunity to benefit from the agility and innovation of smaller companies. However, it’s important to note that small-cap stocks can be more volatile, meaning their prices may rise or fall quickly depending on market conditions.
How much will it cost me?The BNY Mellon US Small Cap Core Equity ETF (Ticker: BKSE) has an expense ratio of 0.04%, meaning you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it is passively managed, tracking an index rather than relying on active management strategies.
What would affect this ETF?The BKSE ETF, focused on U.S. small-cap companies, could benefit from economic growth and innovation in sectors like technology and healthcare, which are among its largest exposures. However, it may face challenges from rising interest rates or economic slowdowns, which can disproportionately impact smaller companies. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings, such as Bloom Energy and Ionis Pharmaceuticals.
BKSE Top 10 Holdings
The BNY Mellon US Small Cap Core Equity ETF (BKSE) is leaning heavily into the innovative spirit of U.S. small-cap companies, with a notable focus on healthcare and technology. Avidity Biosciences is rising on strong technical momentum despite financial hurdles, while Cytokinetics shows mixed signals with optimism around drug approvals but concerns over profitability. Sanmina-Sci is steady, benefiting from robust growth and strategic positioning, while Advanced Energy adds strength with data center revenue gains, though valuation concerns linger. Overall, the fund’s diversified sector exposure balances opportunity and risk, with healthcare and tech driving much of the action.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Avidity Biosciences | 0.42% | $255.50K | $10.82B | 121.08% | 60 Neutral | |
| Sanmina-Sci | 0.40% | $243.03K | $8.76B | 100.66% | 79 Outperform | |
| Arrowhead Pharmaceuticals | 0.39% | $239.57K | $9.52B | 220.78% | 57 Neutral | |
| CareTrust REIT | 0.39% | $236.50K | $8.10B | 25.96% | 80 Outperform | |
| Lumen Technologies | 0.38% | $235.30K | $8.72B | 30.57% | 55 Neutral | |
| Advanced Energy | 0.38% | $231.42K | $8.12B | 83.48% | 67 Neutral | |
| American Healthcare REIT, Inc. | 0.38% | $230.96K | $8.86B | 64.03% | 68 Neutral | |
| JBT Marel | 0.37% | $228.96K | $8.03B | 25.82% | 69 Neutral | |
| Cadence Bank | 0.37% | $226.52K | $8.00B | 20.27% | 72 Outperform | |
| Commercial Metals Company | 0.37% | $225.58K | $7.84B | 23.34% | 71 Outperform |
BKSE Technical Analysis
Positive
―
Price Trends
111.03
Positive
108.56
Positive
101.50
Positive
Market Momentum
1.57
Negative
62.85
Neutral
88.47
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BKSE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 111.58, equal to the 50-day MA of 111.03, and equal to the 200-day MA of 101.50, indicating a bullish trend. The MACD of 1.57 indicates Negative momentum. The RSI at 62.85 is Neutral, neither overbought nor oversold. The STOCH value of 88.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BKSE.
BKSE Peer Comparison
Comparison Results
Performance Comparison
BKSE
BNY Mellon US Small Cap Core Equity ETF
115.63
10.22
9.70%
ITWO
ProShares Russell 2000 High Income ETF
―
―
―
FLQS
Franklin LibertyQ U.S. Small Cap Equity ETF
―
―
―
STXK
Strive 2000 ETF
―
―
―
AFSM
First Trust Active Factor Small Cap ETF
―
―
―
FSCC
Federated Hermes MDT Small Cap Core ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents